The high-resolution crystal structure of the SARS-CoV-2 frameshifting pseudoknot identifies potential binding pockets for future small-molecule antiviral therapeutics.
Identifies candidate pockets for antiviral design; leaves open whether ligands can inhibit frameshifting in cells.
SARS-CoV-2 produces two long viral protein precursors from one open reading frame using a highly conserved RNA pseudoknot that enhances programmed -1 ribosomal frameshifting. The 1.3 Å-resolution X-ray structure of the pseudoknot reveals three coaxially stacked helices buttressed by idiosyncratic base triples from loop residues. This structure represents a frameshift-stimulating state that must be deformed by the ribosome and exhibits base-triple-adjacent pockets that could be targeted by future small-molecule therapeutics.
No takes yet. Share an insight, caveat, or question.
Jones et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: